CliffBio
small molecule

CEFEPIME IN PLASTIC CONTAINER

CEFEPIME HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameCEFEPIME IN PLASTIC CONTAINER
Active ingredientCEFEPIME HYDROCHLORIDE
StrengthEQ 2GM BASE/100ML (EQ 20MG BASE/ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalAugust 2008
Marketing statusRX

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.